VMD Viemed Healthcare, Inc.
Platform & Compounding FCF
B- 65.2 / 100 composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

Profitability

Weight: 25%
D+ 43
  • 5yr Avg ROIC 6.9%
  • Operating Margin Trend -0.24 pp/yr

Capital Efficiency

Weight: 15%
C 52
  • 5yr Avg ROE 7.3%
  • 5yr Share-Count CAGR 0.1%

Growth Quality

Weight: 25%
A 91
  • 5yr Revenue CAGR 23.3%
  • 5yr EPS CAGR 13.9%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 20%
C+ 60
  • 5yr FCF Margin 4.3%
  • 5yr FCF/NI Conversion 0.77x

Balance Sheet

Weight: 10%
A+ 97
  • Net Debt / EBITDA 0.05x
  • Interest Coverage (EBIT/Int) 19.42x
  • Altman Z-Score 6.96

Stability

Weight: 5%
D+ 40
  • EPS Volatility (σ/μ) 1.06
  • Piotroski F-Score 6
  • Negative-Revenue Years (5) 1/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Accumulating

2 of 2 gurus held; 2 added.

Holders
2
Avg Δ position
+24.8%
New buys
0
Full exits
0
As of Q1 2026